Operating Lease, Right-of-Use Asset of LISATA THERAPEUTICS, INC. from 31 Mar 2019 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
LISATA THERAPEUTICS, INC. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Mar 2019 to 30 Sep 2025.
  • LISATA THERAPEUTICS, INC. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $0, a 100% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

LISATA THERAPEUTICS, INC. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $0 -$182,000 -100% 30 Sep 2025 10-Q 06 Nov 2025 2025 Q3
Q2 2025 $47,000 -$178,000 -79% 30 Jun 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 $93,000 -$174,000 -65% 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 $138,000 -$170,000 -55% 31 Dec 2024 10-Q 06 Nov 2025 2025 Q3
Q3 2024 $182,000 -$166,000 -48% 30 Sep 2024 10-Q 12 Nov 2024 2024 Q3
Q2 2024 $225,000 -$162,000 -42% 30 Jun 2024 10-Q 12 Aug 2024 2024 Q2
Q1 2024 $267,000 -$158,000 -37% 31 Mar 2024 10-Q 09 May 2024 2024 Q1
Q4 2023 $308,000 -$179,000 -37% 31 Dec 2023 10-K 27 Feb 2025 2024 FY
Q3 2023 $348,000 -$200,000 -36% 30 Sep 2023 10-Q 02 Nov 2023 2023 Q3
Q2 2023 $387,000 -$221,000 -36% 30 Jun 2023 10-Q 14 Aug 2023 2023 Q2
Q1 2023 $425,000 -$242,000 -36% 31 Mar 2023 10-Q 09 May 2023 2023 Q1
Q4 2022 $487,000 -$237,000 -33% 31 Dec 2022 10-K 29 Feb 2024 2023 FY
Q3 2022 $548,000 +$226,000 +70% 30 Sep 2022 10-Q 10 Nov 2022 2022 Q3
Q2 2022 $608,000 +$200,000 +49% 30 Jun 2022 10-Q 04 Aug 2022 2022 Q2
Q1 2022 $667,000 +$175,000 +36% 31 Mar 2022 10-Q 05 May 2022 2022 Q1
Q4 2021 $724,000 +$150,000 +26% 31 Dec 2021 10-K 30 Mar 2023 2022 FY
Q3 2021 $322,000 -$331,000 -51% 30 Sep 2021 10-Q 04 Nov 2021 2021 Q3
Q2 2021 $408,000 -$323,000 -44% 30 Jun 2021 10-Q 05 Aug 2021 2021 Q2
Q1 2021 $492,000 -$315,000 -39% 31 Mar 2021 10-Q 06 May 2021 2021 Q1
Q4 2020 $574,000 -$332,000 -37% 31 Dec 2020 10-K 22 Mar 2022 2021 FY
Q3 2020 $653,000 -$350,000 -35% 30 Sep 2020 10-Q 05 Nov 2020 2020 Q3
Q2 2020 $731,000 -$362,000 -33% 30 Jun 2020 10-Q 13 Aug 2020 2020 Q2
Q1 2020 $807,000 -$377,000 -32% 31 Mar 2020 10-Q 07 May 2020 2020 Q1
Q4 2019 $906,000 31 Dec 2019 10-K 25 Feb 2021 2020 FY
Q3 2019 $1,003,000 30 Sep 2019 10-Q 06 Nov 2019 2019 Q3
Q2 2019 $1,093,000 30 Jun 2019 10-Q 08 Aug 2019 2019 Q2
Q1 2019 $1,184,000 31 Mar 2019 10-Q 09 May 2019 2019 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.